National Bank Financial Lowers Maricann Group (CNSX:MARI) Price Target to $14.00

Maricann Group (CNSX:MARI) had its price objective reduced by investment analysts at National Bank Financial from $15.00 to $14.00 in a research report issued on Wednesday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock.

Maricann Group Stock Performance

Maricann Group has a 52-week low of $0.87 and a 52-week high of $3.60.

About Maricann Group

Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company’s services a patient base with more than 8,000 registered patients. The Company is undertaking an expansion of the cultivation and support facilities to support existing and future patient growth.